[
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ): Exploring Valuation Perspectives After Recent Share Price Momentum",
    "summary": "Johnson & Johnson (JNJ) shares have edged higher over the past month, building on a steady run that has seen the stock advance 17% in the past 3 months. Investors are watching for what comes next as momentum builds. See our latest analysis for Johnson & Johnson. The share price momentum for Johnson & Johnson has been impressive, with steady gains this year suggesting renewed investor confidence as the company continues to navigate a shifting healthcare landscape. Over the past year, the total...",
    "url": "https://finnhub.io/api/news?id=6e446314292659f151e6998595f37d7005a571a57307fe00c1cb1a9c58364d48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764112634,
      "headline": "Johnson & Johnson (JNJ): Exploring Valuation Perspectives After Recent Share Price Momentum",
      "id": 137611249,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) shares have edged higher over the past month, building on a steady run that has seen the stock advance 17% in the past 3 months. Investors are watching for what comes next as momentum builds. See our latest analysis for Johnson & Johnson. The share price momentum for Johnson & Johnson has been impressive, with steady gains this year suggesting renewed investor confidence as the company continues to navigate a shifting healthcare landscape. Over the past year, the total...",
      "url": "https://finnhub.io/api/news?id=6e446314292659f151e6998595f37d7005a571a57307fe00c1cb1a9c58364d48"
    }
  },
  {
    "ts": null,
    "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
    "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
    "url": "https://finnhub.io/api/news?id=58762239f9e3a404d6f59494acb6333f47cfb175f789b1bd360b1f9dbeee9a22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764097260,
      "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
      "id": 137611250,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
      "url": "https://finnhub.io/api/news?id=58762239f9e3a404d6f59494acb6333f47cfb175f789b1bd360b1f9dbeee9a22"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Kings: November 2025",
    "summary": "Discover which Dividend Kings are outperforming the S&P 500, recent dividend growth trends, and undervalued picks with strong return potential. Click to read.",
    "url": "https://finnhub.io/api/news?id=3f7039d7eca10e1146e996160a33d8cff7916360c0b263b16c61d1d2298eb2a4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764081928,
      "headline": "Best Dividend Kings: November 2025",
      "id": 137606267,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2189850011/image_2189850011.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Discover which Dividend Kings are outperforming the S&P 500, recent dividend growth trends, and undervalued picks with strong return potential. Click to read.",
      "url": "https://finnhub.io/api/news?id=3f7039d7eca10e1146e996160a33d8cff7916360c0b263b16c61d1d2298eb2a4"
    }
  },
  {
    "ts": null,
    "headline": "J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?",
    "summary": "J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.",
    "url": "https://finnhub.io/api/news?id=42ccd668993012cedf9961a5de78b1ccac4b109d2a8e69f66ad59467c5c6ace0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764073440,
      "headline": "J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?",
      "id": 137605788,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.",
      "url": "https://finnhub.io/api/news?id=42ccd668993012cedf9961a5de78b1ccac4b109d2a8e69f66ad59467c5c6ace0"
    }
  },
  {
    "ts": null,
    "headline": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
    "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
    "url": "https://finnhub.io/api/news?id=e60775d825bc07ed9061f399c101c0bc6997bad6a58e91a84a26d48f05888360",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764070200,
      "headline": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
      "id": 137605806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
      "url": "https://finnhub.io/api/news?id=e60775d825bc07ed9061f399c101c0bc6997bad6a58e91a84a26d48f05888360"
    }
  },
  {
    "ts": null,
    "headline": "4 takeaways from pharma’s manufacturing boom",
    "summary": "As pharma’s U.S. facility investments top $370 billion over the next five years, there are a few things to keep in mind, according to construction experts.",
    "url": "https://finnhub.io/api/news?id=233c1cf0383ff95697693c76296957c552c00161be33434d5f001e66289d5726",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764057600,
      "headline": "4 takeaways from pharma’s manufacturing boom",
      "id": 137605790,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "As pharma’s U.S. facility investments top $370 billion over the next five years, there are a few things to keep in mind, according to construction experts.",
      "url": "https://finnhub.io/api/news?id=233c1cf0383ff95697693c76296957c552c00161be33434d5f001e66289d5726"
    }
  },
  {
    "ts": null,
    "headline": "If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?",
    "summary": "Johnson & Johnson (NYSE:JNJ) is a global healthcare company that develops, manufactures, and sells pharmaceutical products and medical devices. It is set to report its Q4 2025 earnings on Jan. 21. Wall Street analysts expect the company to post EPS of ...",
    "url": "https://finnhub.io/api/news?id=72d42450c0b7a89cb2ad5b7168a0db8851b0be0c0aeb5a3cd865a0aa77ac1071",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764039685,
      "headline": "If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?",
      "id": 137601504,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is a global healthcare company that develops, manufactures, and sells pharmaceutical products and medical devices. It is set to report its Q4 2025 earnings on Jan. 21. Wall Street analysts expect the company to post EPS of ...",
      "url": "https://finnhub.io/api/news?id=72d42450c0b7a89cb2ad5b7168a0db8851b0be0c0aeb5a3cd865a0aa77ac1071"
    }
  }
]